Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Neoleukin Therapeutics, Inc. | Financial_Report.xls |
| EX-32.1 - EX-32.1 - Neoleukin Therapeutics, Inc. | d851032dex321.htm |
| EX-32.2 - EX-32.2 - Neoleukin Therapeutics, Inc. | d851032dex322.htm |
| EX-31.1 - EX-31.1 - Neoleukin Therapeutics, Inc. | d851032dex311.htm |
| 10-K - 10-K - Neoleukin Therapeutics, Inc. | d851032d10k.htm |
| EX-31.2 - EX-31.2 - Neoleukin Therapeutics, Inc. | d851032dex312.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement on Form S-8 of our report dated March 16, 2015, relating to the financial statements of Aquinox Pharmaceuticals, Inc. appearing in this Annual Report on Form 10-K of Aquinox Pharmaceutical, Inc. for the year ended December 31, 2014.
/s/ Deloitte LLP
Vancouver, Canada
March 16, 2015